Bentham Science Logo

Track Your Manuscript:

Current Drug Discovery Technologies

Volume 19, 6 Issues, 2022
ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)
This journal supports open access

Authors' Comments

"Working with the Bentham Science Editorial team has been a very rewarding experience for me. I find the staff highly trained, organized and professional. This experience has made it a pleasure to publish with Bentham Sciences because the support is so helpful. Staff have been encouraging, patient and very detail oriented while helping me to fine-tune my manuscript(s) into their final format ready for public viewing. Publishing is a challenge for me due to time constraints and a full-time teaching assignment but working with the Bentham Science group has been a pleasure. "

Kimberly A. Stieglitz
(STEM Biotechnology Division, Roxbury Community College, Roxbury, MA, United States)

"I am very pleased with the quality of service that I received from every part of Bentham Science, including your journal, Current Drug Discovery Technologies. First, let me thank you and the editor for inviting me to submit a review article. The 2nd edition was written as a text for the first semester of the two semester course in medicinal chemistry that is taught in pharmacy schools around the world. Bentham Science is doing a great job of helping my books reach the market.

At the same time, the article I wrote for Current Drug Discovery Technologies gave me an opportunity to reach a broader audience than the one that I reach in my research on food and natural products chemistry at the FDA. It also gave me the opportunity to review the very important subject of allo-network drugs, which has emerged recently and is described in more detail in the 3rd edition. The review process was fast and efficient. It caught the mistakes that I made and recommended several important improvements. The final proofs look excellent.

The other thing that Bentham Science has done for me is to greatly increase my scientific reputation, which has led to several other publishers inviting me to write review articles for them. In conclusion, Bentham Science continues to support my career and I hope that you have found me to be a valuable contributor."

Dr. Robert E. Smith
(U.S. FDA, 11510 W 80th St., Lenexa, KS 66214, USA)


Vladimir P. Torchilin
(81376 citations)
Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, Massachusetts
(United States)
View Full Editorial Board

COPE Compliant

Cope Logo
New eBook

You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog